Skip to main
BDX

BDX Stock Forecast & Price Target

BDX Analyst Ratings

Based on 14 analyst ratings
Buy
Strong Buy 29%
Buy 21%
Hold 50%
Sell 0%
Strong Sell 0%

Bulls say

Becton Dickinson is expected to continue to see growth in all four of its business units, with strong performance and a focus on shareholder returns through dividends and share repurchases. The company also has a strong pipeline for potential acquisitions and has announced key product launches for the fiscal year. While the separation of its Lifesciences business may drive future growth, challenges in certain segments and regions may impact its performance in the near term. Overall, Becton Dickinson has strong financials and a positive outlook, with a potential stock value ranging from $140 to $185.

Bears say

Becton Dickinson is expected to generate average HSD EPS growth through the projected period of FY2030, aided by their BD Excellence initiative to drive margin expansion and accelerate revenue growth. However, there are several risks that may impact the company's growth, including potential challenges with the separation of its Biosciences and Diagnostics divisions and ongoing headwinds in the industry such as funding cuts and changing healthcare delivery and reimbursement practices. Furthermore, competition in all segments and global economic conditions may also create headwinds for the company's operations.

BDX has been analyzed by 14 analysts, with a consensus rating of Buy. 29% of analysts recommend a Strong Buy, 21% recommend Buy, 50% suggest Holding, 0% advise Selling, and 0% predict a Strong Sell.

This aggregate rating is based on analysts' research of Becton, Dickinson and Co. and is not a guaranteed prediction by Public.com or investment advice.

Order type

Buy in

Order amount

Est. shares

0 shares

Sign up to buy

FAQs About Becton, Dickinson and Co. (BDX) Forecast

Analysts have given BDX a Buy based on their latest research and market trends.

According to 14 analysts, BDX has a Buy consensus rating as of Jul 16, 2026. This rating is provided by third-party analysts and is not investment advice from Public.com.

Wall Street analysts have set a price target of $184.36, reflecting a 0.00% increase from the current stock price.

Financial analysts have set a price target of $184.36, indicating a 0.00% increase from the current stock price, but ratings and forecasts are frequently updated based on market conditions, earnings reports, and industry trends. This prediction is provided by third-party analysts and is not investment advice from Public.com.

Becton, Dickinson and Co. (BDX)


Order type

Buy in

Order amount

Est. shares

0 shares

Sign up to buy
Disclaimer: Any investment listed here, which may be available on the Public platform, is intended to be used for informational purposes only, should not be the sole basis for making an investment decision, and is not a recommendation or advice.